248 related articles for article (PubMed ID: 87887)
21. Pap smear rates among Haitian immigrant women in eastern Massachusetts.
Green EH; Freund KM; Posner MA; David MM
Public Health Rep; 2005; 120(2):133-9. PubMed ID: 15842114
[TBL] [Abstract][Full Text] [Related]
22. [Coverage of Pap smear tests in the city of São Leopoldo, Rio Grande do Sul State, Brazil].
Muller DK; Dias-da-Costa JS; Luz AM; Olinto MT
Cad Saude Publica; 2008 Nov; 24(11):2511-20. PubMed ID: 19009131
[TBL] [Abstract][Full Text] [Related]
23. The evaluation of cervical cancer screening by combining speculoscopy with Papanicolaou smear examination in Taiwan.
Chang JI; Ou CH; Wu KM; Chen CC; Cheng KC
Zhonghua Yi Xue Za Zhi (Taipei); 2002 Sep; 65(9):430-4. PubMed ID: 12433029
[TBL] [Abstract][Full Text] [Related]
24. Organised vs. spontaneous Pap-smear screening for cervical cancer: A case-control study.
Nieminen P; Kallio M; Anttila A; Hakama M
Int J Cancer; 1999 Sep; 83(1):55-8. PubMed ID: 10449608
[TBL] [Abstract][Full Text] [Related]
25. Pap smear screening, pap smear abnormalities and psychosocial risk factors among women in a residential alcohol and drug rehabilitation facility.
Soccio J; Brown M; Comino E; Friesen E
J Adv Nurs; 2015 Dec; 71(12):2858-66. PubMed ID: 26279461
[TBL] [Abstract][Full Text] [Related]
26. Merits and pitfalls of normal saline rehydrated air-dried cervical smears over conventional wet.fixed PAP smears: A comparative study.
Kamble SA; Dombale VD; Shah F
Indian J Pathol Microbiol; 2022; 65(1):100-104. PubMed ID: 35074972
[TBL] [Abstract][Full Text] [Related]
27. Papanicolaou smear screening interval and risk of cervical cancer.
Shy K; Chu J; Mandelson M; Greer B; Figge D
Obstet Gynecol; 1989 Dec; 74(6):838-43. PubMed ID: 2586947
[TBL] [Abstract][Full Text] [Related]
28. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
[TBL] [Abstract][Full Text] [Related]
29. Papanicolaou smear: can we make a good test better? Technical and interpretive challenges for the practitioner.
Eltabbakh GH; Eltabbakh GD
J Womens Health Gend Based Med; 1999 May; 8(4):469-76. PubMed ID: 10839701
[TBL] [Abstract][Full Text] [Related]
30. Cytohistologic correlation rates between conventional Papanicolaou smears and ThinPrep cervical cytology: a comparison.
Chacho MS; Mattie ME; Schwartz PE
Cancer; 2003 Jun; 99(3):135-40. PubMed ID: 12811853
[TBL] [Abstract][Full Text] [Related]
31. The screening histories of women with invasive cervical cancer, Connecticut.
Janerich DT; Hadjimichael O; Schwartz PE; Lowell DM; Meigs JW; Merino MJ; Flannery JT; Polednak AP
Am J Public Health; 1995 Jun; 85(6):791-4. PubMed ID: 7762711
[TBL] [Abstract][Full Text] [Related]
32. Limited Pap screening associated with reduced risk of cervical cancer in South Africa.
Hoffman M; Cooper D; Carrara H; Rosenberg L; Kelly J; Stander I; Williamson AL; Denny L; du Toit G; Shapiro S
Int J Epidemiol; 2003 Aug; 32(4):573-7. PubMed ID: 12913031
[TBL] [Abstract][Full Text] [Related]
33. Low uptake of Pap smear testing among medical clinic attendees in a tertiary care hospital in Sri Lanka.
Shivanthan MC; Arunakiri K; Wickramasinghe SI; Sumanasekera RD; Jayasinghe S; Rajapakse S
Int Health; 2014 Jun; 6(2):138-43. PubMed ID: 24737803
[TBL] [Abstract][Full Text] [Related]
34. The cytological screening turned out effective also for adenocarcinoma: a population-based case-control study in Trento, Italy.
Crocetti E; Battisti L; Betta A; Palma PD; Paci E; Piffer S; Pojer A; Polla E; Zappa M
Eur J Cancer Prev; 2007 Dec; 16(6):564-7. PubMed ID: 18090131
[TBL] [Abstract][Full Text] [Related]
35. Screening practices and invasive cervical cancer risk in different age strata.
Parazzini F; Negri E; La Vecchia C; Bocciolone L
Gynecol Oncol; 1990 Jul; 38(1):76-80. PubMed ID: 2354830
[TBL] [Abstract][Full Text] [Related]
36. [Pap smear coverage and factors associated with non-participation in cervical cancer screening: an analysis of the Cervical Cancer Prevention Program in Pernambuco State, Brazil].
Albuquerque KM; Frias PG; Andrade CL; Aquino EM; Menezes G; Szwarcwald CL
Cad Saude Publica; 2009; 25 Suppl 2():S301-9. PubMed ID: 19684937
[TBL] [Abstract][Full Text] [Related]
37. Relationships between Self-Efficacy and Pap Smear Screening in Iranian Women.
Majdfar Z; Khodadost M; Majlesi F; Rahimi A; Shams M; Mohammadi G
Asian Pac J Cancer Prev; 2016; 17(S3):263-8. PubMed ID: 27165236
[TBL] [Abstract][Full Text] [Related]
38. Screening History Among Women with Invasive Cervical Cancer in an Academic Medical Center: Will We Miss Cancers Following Updated Guidelines?
Nitschmann C; May T; Mirkovic J; Feldman S
J Womens Health (Larchmt); 2016 Aug; 25(8):826-31. PubMed ID: 26859535
[TBL] [Abstract][Full Text] [Related]
39. Limited Understanding of Pap Smear Testing among Women, a Barrier to Cervical Cancer Screening in the United Arab Emirates.
AL-Hammadi FA; Al-Tahri F; Al-Ali A; Nair SC; Abdulrahman M
Asian Pac J Cancer Prev; 2017 Dec; 18(12):3379-3387. PubMed ID: 29286607
[TBL] [Abstract][Full Text] [Related]
40. Longitudinal analysis of histologic high-grade disease after negative cervical cytology according to endocervical status.
Mitchell HS
Cancer; 2001 Aug; 93(4):237-40. PubMed ID: 11507695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
